Is the Antithrombotic Activity of “Antiplatelet” Drugs Based on Protection of Endothelium?

Summary

In only five “antiplatelet” agents has the antithrombotic activity been confirmed both clinically and experimentally. These include acetylsalicylic acid, dipyridamole, clofibrate, hydroxychloroquine and sulfinpyrazone. Whereas only acetylsalicylic acid has a demonstrable effect on platelet aggregation in doses usually applied, the effects of all remaining drugs are more easily explained by their influence on the vessel wall. This assumption is supported by the finding that all five drugs possess a stabilizing effect on endothelium in doses corresponding closely to the clinical dose range. The method based on counting detached endothelial cells in blood after a standard stimulus was used to demonstrate this effect.

• References

• 1 Bouvier CA. 1972; Rôle des lésions endothéliales dans la thrombogenése. Médicine et Hygiéne 30: 653
• 2 Hladovec J. 1977; Vasotropic drugs - a survey based on a unifying concept of their mechanism of action. Arzneimittel-Forschung 27: 1073
• 3 Hladovec J. 1978 The influence of calcium antagonists on endothelium. Arzneimittel-Forschung (in print).
• 4 Hladovec J. 1978 Comparison of endothelial-protective activities of clofibrate, pyridinolcarbamate and a benzopyrone combination drug (Venalot®). Vasa (in print).
• 5 Hladovec J, Rossmann P. 1973; Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats. Thrombosis Research 3: 665
• 6 Nachman RL. 1975; The platelet-endothelial cell-VIII axis. Vth Congress of Thrombosis and Haemostasis, Paris, Abstr. p. 460: 1975
• 7 Verstraete M. 1976; Are agents affecting platelet functions clinically useful American Journal of Medicine. 61: 897
• 8 Weiss HJ. 1976; Antiplatelet drugs-A new pharmacologic approach to the prevention of thrombosis. American Heart Journal 92: 86